Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Post by PowerofNowon Oct 29, 2018 9:47am
348 Views
Post# 28886505

NEWS: FP Says FSD Pharma Anxiously Waiting for Licence

NEWS: FP Says FSD Pharma Anxiously Waiting for Licence

The Financial Post reports in its Saturday, Oct. 27, edition that the cannabis industry is still reeling from sky-high demand in the second week of legalization with growers expressing frustration at the length of time it is taking to get licensed as shelves sit empty.

A Bloomberg dispatch to the Post reports that FSD Pharma director Anthony Durkacz says, "We're biting our nails and I think our shareholders are biting their nails, too." FSD Pharma is an Ontario-based producer that received its cultivation licence a year ago and is still waiting for its sales licence. Mr. Durkacz says, "We want to be supplying." The process of getting a sales licence from Health Canada is onerous, according to Mr. Durkacz. He says after receiving a cultivation licence, a grower must produce two full crops, send them off for testing, get its sales software audited, and then submit a completed application for the sales licence, which can take up to 341 days to process. "So even after you've done everything and done everything right you could be waiting up to a year to get the licence," he says. While some growers wait for their licences, others are struggling to keep up with demand.

© 2018 Canjex Publishing Ltd. All rights reserved

READ:  https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aHUGE-2675191&symbol=HUGE&region=C

Bullboard Posts